Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024

被引：0

作者：

Link-Gelles, Ruth ^{[1
]}

Rowley, Elizabeth A. K. ^{[2
]}

DeSilva, Malini B. ^{[3
]}

Dascomb, Kristin ^{[4
]}

Irving, Stephanie A. ^{[5
]}

Klein, Nicola P. ^{[6
]}

Grannis, Shaun J. ^{[7
,8
]}

Ong, Toan C. ^{[9
]}

Weber, Zachary A. ^{[2
]}

Fleming-Dutra, Katherine E. ^{[1
]}

McEvoy, Charlene E. ^{[3
]}

Akinsete, Omobosola ^{[3
]}

Bride, Daniel ^{[10
]}

Sheffield, Tamara ^{[11
]}

Naleway, Allison L. ^{[5
]}

Zerbo, Ousseny ^{[6
]}

Fireman, Bruce ^{[6
]}

Hansen, John ^{[6
]}

Goddard, Kristin ^{[6
]}

Dixon, Brian E. ^{[7
,12
]}

Rogerson, Colin ^{[7
,13
]}

Fadel, William F. ^{[7
,14
]}

Duszynski, Thomas ^{[7
,15
]}

Rao, Suchitra ^{[9
]}

Barron, Michelle A. ^{[9
]}

Reese, Sarah E. ^{[2
]}

Ball, Sarah W. ^{[2
]}

Dunne, Margaret M. ^{[2
]}

Natarajan, Karthik ^{[16
]}

Okwuazi, Erica ^{[17
]}

Shah, Ami B. ^{[17
]}

Wiegand, Ryan ^{[1
]}

Tenforde, Mark W. ^{[18
]}

Payne, Amanda B. ^{[1
]}

机构：

[1] Natl Ctr Immunizat & Resp Dis, Coronavirus & Other Resp Viruses Div, CDC, Atlanta, GA 30333 USA

[2] Westat Corp, Rockville, MD USA

[3] HealthPartners Inst, Minneapolis, MN USA

[4] Intermt Healthcare, Div Infect Dis & Clin Epidemiol, Salt Lake City, UT USA

[5] Kaiser Permanente Ctr Hlth Res, Portland, OR USA

[6] Kaiser Permanente Northern Calif, Oakland, CA USA

[7] Ctr Biomed Informat, Regenstrief Inst, Indianapolis, IN USA

[8] Indiana Univ, Sch Med, Dept Family Med, Indianapolis, IN USA

[9] Univ Colorado, Anschutz Med Campus, Aurora, CO USA

[10] Intermt Hlth, Enterprise Analyt, Salt Lake City, UT USA

[11] Immunizat Programs, Intermt Hlth, Salt Lake City, UT USA

[12] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Hlth Policy & Management, Indianapolis, IN USA

[13] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN USA

[14] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Biostat & Hlth Data Sci, Indianapolis, IN USA

[15] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN USA

[16] Columbia Univ, Irving Med Ctr, Dept Biomed Informat, New York, NY USA

[17] Gen Dynam Informat Technol, Falls Church, VA USA

[18] CDC, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA

来源：

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2024年 / 73卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

In September 2023, CDC's Advisory Committee on Immunization Practices recommended updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccination for all persons aged >= 6 months to prevent COVID-19, including severe disease. As with past COVID-19 vaccines, additional doses may be considered for persons with immunocompromising conditions, who are at higher risk for severe COVID-19 and might have decreased response to vaccination. In this analysis, vaccine effectiveness (VE) of an updated COVID-19 vaccine dose against COVID-19-associated hospitalization was evaluated during September 2023-February 2024 using data from the VISION VE network. Among adults aged >= 18 years with immunocompromising conditions, VE against COVID-19- associated hospitalization was 38% in the 7-59 days after receipt of an updated vaccine dose and 34% in the 60-119 days after receipt of an updated dose. Few persons (18%) in this high -risk study population had received updated COVID-19 vaccine. All persons aged >= 6 months should receive updated 2023-2024 COVID-19 vaccination; persons with immunocompromising conditions may get additional updated COVID-19 vaccine doses >= 2 months after the last recommended COVID-19 vaccine.

引用

页码：271 / 276

页数：6

共 43 条

[1] Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024
DeCuir, Jennifer
Payne, Amanda B.
Self, Wesley H.
Rowley, Elizabeth A. K.
Dascomb, Kristin
DeSilva, Malini B.
Irving, Stephanie A.
Grannis, Shaun J.
Ong, Toan C.
Klein, Nicola P.
Weber, Zachary A.
Reese, Sarah E.
Ball, Sarah W.
Barron, Michelle A.
Naleway, Allison L.
Dixon, Brian E.
Essien, Inih
Bride, Daniel
Natarajan, Karthik
Fireman, Bruce
Shah, Ami B.
Okwuazi, Erica
Wiegand, Ryan
Zhu, Yuwei
Lauring, Adam S.
Martin, Emily T.
Gaglani, Manjusha
Peltan, Ithan D.
Brown, Samuel M.
Ginde, Adit A.
Mohr, Nicholas M.
Gibbs, Kevin W.
Hager, David N.
Prekker, Matthew
Mohamed, Amira
Srinivasan, Vasisht
Steingrub, Jay S.
Khan, Akram
Busse, Laurence W.
Duggal, Abhijit
Wilson, Jennifer G.
Chang, Steven Y.
Mallow, Christopher
Kwon, Jennie H.
Exline, Matthew C.
Columbus, Cristie
Vaughn, Ivana A.
Safdar, Basmah
Mosier, Jarrod M.
Harris, Estelle S.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2024, 73 (08): : 180 - 188
[2] Interim effectiveness of the updated 2023-2024 COVID-19 vaccines in adults with immunocompromizing conditions
Pereira, Marcus R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (06) : 890 - 891
[3] Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024
Ma, Kevin C.
Surie, Diya
Lauring, Adam S.
Martin, Emily T.
Leis, Aleda M.
Papalambros, Leigh
Gaglani, Manjusha
Columbus, Christie
Gottlieb, Robert L.
Ghamande, Shekhar
Peltan, Ithan D.
Brown, Samuel M.
Ginde, Adit A.
Mohr, Nicholas M.
Gibbs, Kevin W.
Hager, David N.
Saeed, Safa
Prekker, Matthew E.
Gong, Michelle Ng
Mohamed, Amira
Johnson, Nicholas J.
Srinivasan, Vasisht
Steingrub, Jay S.
Khan, Akram
Hough, Catherine L.
Duggal, Abhijit
Wilson, Jennifer G.
Qadir, Nida
Chang, Steven Y.
Mallow, Christopher
Kwon, Jennie H.
Parikh, Bijal
Exline, Matthew C.
Vaughn, Ivana A.
Ramesh, Mayur
Safdar, Basmah
Mosier, Jarrod
Harris, Estelle S.
Shapiro, Nathan, I
Felzer, Jamie
Zhu, Yuwei
Grijalva, Carlos G.
Halasa, Natasha
Chappell, James D.
Womack, Kelsey N.
Rhoads, Jillian P.
Baughman, Adrienne
Swan, Sydney A.
Johnson, Cassandra A.
Rice, Todd W.
CLINICAL INFECTIOUS DISEASES, 2024,
[4] Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023
Decuir, Jennifer
Surie, Diya
Zhu, Yuwei
Lauring, Adam S.
Gaglani, Manjusha
Mcneal, Tresa
Ghamande, Shekhar
Peltan, Ithan D.
Brown, Samuel M.
Ginde, Adit A.
Steinwand, Aimee
Mohr, Nicholas M.
Gibbs, Kevin W.
Hager, David N.
Ali, Harith
Frosch, Anne
Gong, Michelle N.
Mohamed, Amira
Johnson, Nicholas J.
Srinivasan, Vasisht
Steingrub, Jay S.
Khan, Akram
Busse, Laurence W.
Duggal, Abhijit
Wilson, Jennifer G.
Qadir, Nida
Chang, Steven Y.
Mallow, Christopher
Kwon, Jennie H.
Exline, Matthew C.
Shapiro, Nathan I.
Columbus, Cristie
Vaughn, Ivana A.
Ramesh, Mayur
Safdar, Basmah
Mosier, Jarrod M.
Casey, Jonathan D.
Talbot, H. Keipp
Rice, Todd W.
Halasa, Natasha
Chappell, James D.
Grijalva, Carlos G.
Baughman, Adrienne
Womack, Kelsey N.
Rhoads, Jillian P.
Swan, Sydney A.
Johnson, Cassandra
Lewis, Nathaniel
Ellington, Sascha
Dawood, Fatimah S.
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (11)
[5] Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024
Link-Gelles, Ruth
Ciesla, Allison Avrich
Mak, Josephine
Miller, Joseph D.
Silk, Benjamin J.
Lambrou, Anastasia S.
Paden, Clinton R.
Shirk, Philip
Britton, Amadea
Smith, Zachary R.
Fleming-Dutra, Katherine E.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2024, 73 (04): : 77 - 83
[6] Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024
Antunes, Liliana
Mazagatos, Clara
Martinez-Baz, Ivan
Naesens, Reinout
Borg, Maria-Louise
Petrovic, Goranka
Fatukasi, Terra
Jancoriene, Ligita
Machado, Ausenda
Oroszi, Beatrix
Husa, Petr
Lazar, Mihaela
Duerrwald, Ralf
Howard, Jennifer
Melo, Aryse
Perez-Gimeno, Gloria
Castilla, Jesus
Bernaert, Eva
Dziugyte, Ausra
Makaric, Zvjezdana Lovric
Fitzgerald, Margaret
Mickiene, Aukse
Gomez, Veronica
Turi, Gergo
Souckova, Lenka
Marin, Alexandru
Tolksdorf, Kristin
Nicolay, Nathalie
Rose, Angela M. C.
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (08)
[7] Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study
Monge, Susana
Humphreys, James
Nicolay, Nathalie
Braeye, Toon
Van Evercooren, Izaak
Hansen, Christian Holm
Emborg, Hanne-Dorthe
Sacco, Chiara
Mateo-Urdiales, Alberto
Castilla, Jesus
Martinez-Baz, Ivan
de Gier, Brechje
Hahne, Susan
Meijerink, Hinta
Kristoffersen, Anja Brathen
Machado, Ausenda
Soares, Patricia
Nardone, Anthony
Bacci, Sabrina
Kissling, Esther
Nunes, Baltazar
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (04)
[8] Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up A Target Trial Emulation
Ioannou, George N.
Berry, Kristin
Rajeevan, Nallakkandi
Li, Yuli
Yan, Lei
Huang, Yuan
Lin, Hung-Mo
Bui, David
Hynes, Denise M.
Rowneki, Mazhgan
Bohnert, Amy
Boyko, Edward J.
Iwashyna, Theodore J.
Maciejewski, Matthew L.
Smith, Valerie A.
Berkowitz, Theodore S. Z.
O'Hare, Ann M.
Viglianti, Elizabeth M.
Aslan, Mihaela
Bajema, Kristina L.
ANNALS OF INTERNAL MEDICINE, 2025,
[9] Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota
Ricke, I. J.
Spaulding, A. B.
Rajtar, N. N.
Benton, E. M.
Anderson, I. G.
Lundberg, L.
Mussiel, A.
Nguyen, R. H. N.
VACCINE, 2024, 42 (15) : 3499 - 3504
[10] Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025
Link-Gelles, Ruth
Chickery, Sean
Webber, Alexander
Ong, Toan C.
Rowley, Elizabeth A. K.
Desilva, Malini B.
Dascomb, Kristin
Irving, Stephanie A.
Klein, Nicola P.
Grannis, Shaun J.
Barron, Michelle A.
Reese, Sarah E.
Mcevoy, Charlene
Sheffield, Tamara
Naleway, Allison L.
Zerbo, Ousseny
Rogerson, Colin
Self, Wesley H.
Zhu, Yuwei
Lauring, Adam S.
Martin, Emily T.
Peltan, Ithan D.
Ginde, Adit A.
Mohr, Nicholas M.
Gibbs, Kevin W.
Hager, David N.
Prekker, Matthew E.
Mohamed, Amira
Johnson, Nicholas
Steingrub, Jay S.
Khan, Akram
Felzer, Jamie R.
Duggal, Abhijit
Wilson, Jennifer G.
Qadir, Nida
Mallow, Christopher
Kwon, Jennie H.
Columbus, Cristie
Vaughn, Ivana A.
Safdar, Basmah
Mosier, Jarrod M.
Harris, Estelle S.
Chappell, James D.
Halasa, Natasha
Johnson, Cassandra
Natarajan, Karthik
Lewis, Nathaniel M.
Ellington, Sascha
Reeves, Emily L.
Decuir, Jennifer
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2025, 74 (06): : 73 - 82

← 1 2 3 4 5 →